Kinase Inhibitor News and Research

RSS
A protein kinase inhibitor is a type of enzyme inhibitor that specifically blocks the action of one or more protein kinases.
Experimental drug provides powerful therapy against acute myeloid leukemia

Experimental drug provides powerful therapy against acute myeloid leukemia

Cocktail of two drugs heals damaged hearts

Cocktail of two drugs heals damaged hearts

Gleevec may cause heart problems

Gleevec may cause heart problems

Nexavar approved in Europe for treatment of advanced kidney cancer

Nexavar approved in Europe for treatment of advanced kidney cancer

Dasatinib offers new options for leukemia patients

Dasatinib offers new options for leukemia patients

New data show Enzastaurin's activity across multiple cancer cell lines

New data show Enzastaurin's activity across multiple cancer cell lines

Novel animal model of lung adenocarcinoma

Novel animal model of lung adenocarcinoma

New compound shows unique potency against cancer cell proliferation

New compound shows unique potency against cancer cell proliferation

A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in glioma

A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in glioma

Therapy for metastatic renal cell carcinoma remains inadequate

Therapy for metastatic renal cell carcinoma remains inadequate

Lilly launches phase III trial of Enzastaurin

Lilly launches phase III trial of Enzastaurin

Novel mouse model of medulloblastoma

Novel mouse model of medulloblastoma

Australian researchers determine structure of JAK2 kinase, huge implications for development of new cancer drugs

Australian researchers determine structure of JAK2 kinase, huge implications for development of new cancer drugs

Raf Kinase Inhibitor Protein plays a role in controlling the active movement of cells

Raf Kinase Inhibitor Protein plays a role in controlling the active movement of cells

Tarceva should be tested as front-line therapy for older lung cancer patients

Tarceva should be tested as front-line therapy for older lung cancer patients

Study examines biomarkers for response to erlotinib in glioma

Study examines biomarkers for response to erlotinib in glioma

Triple approach is promising against cancer cells

Triple approach is promising against cancer cells

New anticancer drug SU11248 shows continued response for patients with late-stage kidney cancer

New anticancer drug SU11248 shows continued response for patients with late-stage kidney cancer

Study identifies possible marker for efficacy of gefitinib in lung cancer patients

Study identifies possible marker for efficacy of gefitinib in lung cancer patients

FDA to change regulations regarding side-effect information in drug ads

FDA to change regulations regarding side-effect information in drug ads